Absolute Iron Deficiency Anemia Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
作者信息
Winicki Nolan M, Florissi Isabella S, Radomski Shannon N, Johnston Fabian M, Greer Jonathan B
机构信息
Division of Gastrointestinal Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
Ann Surg Oncol. 2023 Jun;30(6):3188-3190. doi: 10.1245/s10434-023-13262-4. Epub 2023 Feb 25.
Abstract
摘要
相似文献
1
Absolute Iron Deficiency Anemia Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.细胞减灭术和热灌注化疗后出现的绝对性缺铁性贫血
Ann Surg Oncol. 2023 Jun;30(6):3188-3190. doi: 10.1245/s10434-023-13262-4. Epub 2023 Feb 25.
2
Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.减瘤手术联合腹腔热灌注化疗后的器官特异性不良反应
Ann Surg Oncol. 2022 Sep;29(9):6049-6083. doi: 10.1245/s10434-022-11356-z. Epub 2022 Feb 25.
3
ASO Author Reflections: Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Scoping Review.ASO作者反思：减瘤手术联合热灌注化疗后的器官特异性不良反应——一项范围综述
Ann Surg Oncol. 2022 Sep;29(9):6084-6085. doi: 10.1245/s10434-022-11426-2. Epub 2022 Feb 21.
4
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer: A long way to go.胃癌的细胞减灭术加腹腔内热化疗：任重道远。
Eur J Cancer. 2024 Mar;199:113554. doi: 10.1016/j.ejca.2024.113554. Epub 2024 Jan 15.
5
ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis.ASO作者反思：减瘤手术联合腹腔热灌注化疗治疗伴腹膜转移的胃癌：一项系统评价和荟萃分析
Ann Surg Oncol. 2022 Nov;29(12):7538-7539. doi: 10.1245/s10434-022-12317-2. Epub 2022 Jul 30.
6
ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University.ASO作者反思：维克森林大学开展热灌注化疗（HIPEC）联合重复细胞减灭术三十年
Ann Surg Oncol. 2022 Jun;29(6):3446-3447. doi: 10.1245/s10434-022-11514-3. Epub 2022 Mar 11.
7
ASO Author Reflections: Changes in Coagulation Biomarkers and the Risk for Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：细胞减灭术和热灌注化疗后凝血生物标志物的变化及静脉血栓栓塞风险
Ann Surg Oncol. 2021 Nov;28(12):7783. doi: 10.1245/s10434-021-09960-6. Epub 2021 May 14.
8
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for a limited low-grade pseudomyxoma peritonei-a video vignette.腹腔镜减瘤手术联合腹腔内热灌注化疗治疗局限性低度黏液性腹膜假黏液瘤——视频病例
Colorectal Dis. 2021 Jan;23(1):331-332. doi: 10.1111/codi.15409. Epub 2020 Nov 10.
9
ASO Author Reflections: Delayed Occurrence and Postoperative Risks of Mitomycin-C-Induced Neutropenia After Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：热灌注化疗后丝裂霉素C诱导的中性粒细胞减少症的延迟发生及术后风险
Ann Surg Oncol. 2022 Mar;29(3):2087-2088. doi: 10.1245/s10434-021-11000-2. Epub 2021 Oct 23.
10
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?细胞减灭术和腹腔热灌注化疗治疗结直肠腹膜转移：我们处于什么位置？
Cancer. 2023 Feb 15;129(4):495-502. doi: 10.1002/cncr.34567. Epub 2022 Dec 16.
本文引用的文献
1
Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer.局部晚期肛门癌放化疗后急性和迟发性胃肠道毒性的剂量学和临床预测因素。
Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e35-e44. doi: 10.1016/j.clon.2021.09.011. Epub 2021 Sep 28.
2
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.围手术期输血对高热腹腔化疗后结局的影响：倾向评分匹配分析。
Ann Surg Oncol. 2021 Aug;28(8):4499-4507. doi: 10.1245/s10434-020-09501-7. Epub 2021 Jan 28.
3
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.细胞减灭术（CRS）联合或不联合腹腔内热灌注化疗（HIPEC）围手术期护理指南：手术后加速康复（ERAS®）协会推荐 - 第一部分：术前和术中管理。
Eur J Surg Oncol. 2020 Dec;46(12):2292-2310. doi: 10.1016/j.ejso.2020.07.041. Epub 2020 Aug 25.
4
Management of Iron Deficiency Anemia.缺铁性贫血的管理
Gastroenterol Hepatol (N Y). 2015 Apr;11(4):241-50.
5
Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I.妇科/肿瘤外科手术围手术期护理指南：术后加速康复（ERAS®）学会推荐意见——第一部分
Gynecol Oncol. 2016 Feb;140(2):313-22. doi: 10.1016/j.ygyno.2015.11.015. Epub 2015 Nov 18.
6
Chronic anemia due to mitomycin C is drug dose-dependent, normocytic, progressive, related to erythropoietin levels and quantitatively predictable: implications for radiochemotherapy.丝裂霉素C所致的慢性贫血呈药物剂量依赖性、正细胞性、进行性，与促红细胞生成素水平相关且在数量上可预测：对放化疗的意义。
J Chemother. 2011 Dec;23(6):362-6. doi: 10.1179/joc.2011.23.6.362.
7
Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials.铁剂联合促红细胞生成素治疗癌症患者：一项随机试验的荟萃分析。
J Cancer Res Clin Oncol. 2012 Feb;138(2):179-87. doi: 10.1007/s00432-011-1072-3. Epub 2011 Oct 5.
Zotero 插件